Used primarily in the development of pharmaceuticals, this compound serves as a key intermediate in the synthesis of selective serotonin reuptake inhibitors (SSRIs). It plays a critical role in enhancing the bioavailability and metabolic stability of active drug substances. Due to its chiral and structural specificity, it is especially valuable in creating enantiomerically pure medications for treating depression and anxiety disorders. Its cyclohexane and pyridine moieties contribute to strong receptor binding affinity, making it effective in central nervous system therapies. Additionally, it has been explored in the design of kinase inhibitors for potential oncology applications.